BlackRock
BNGO icon

BlackRock’s Bionano Genomics BNGO Stock Holding History

BlackRock’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2K Hold
9,937
– – ﹤0.01% 5426
2026
Q1 		$11.6K Hold
9,937
– – ﹤0.01% 5386
2025
Q4 		$15.2K Hold
9,937
– – ﹤0.01% 5256
2025
Q3 		$17K Buy
9,937
+1
+0% +$3 ﹤0.01% 5170
2025
Q2 		$32.6K Sell
9,936
-167
-2% -$623 ﹤0.01% 5067
2025
Q1 		$28.2K Sell
10,103
-4
-0% -$26 ﹤0.01% 5032
2024
Q4 		$175K Sell
10,107
-129
-1% -$2.21K ﹤0.01% 4650
2024
Q3 		$279K Buy
10,236
+108
+1% +$3.36K ﹤0.01% 4458
2024
Q2 		$412K Buy
10,128
+3,705
+58% +$204K ﹤0.01% 4394
2024
Q1 		$428K Sell
6,423
-2,000
-24% -$149K ﹤0.01% 4407
2023
Q4 		$955K Sell
8,423
-1,165
-12% -$122K ﹤0.01% 4273
2023
Q3 		$1.74M Sell
9,588
-640
-6% -$168K ﹤0.01% 4049
2023
Q2 		$3.74M Sell
10,228
-28,545
-74% -$12.9M ﹤0.01% 3827
2023
Q1 		$25.8M Buy
38,773
+39
+0.1% +$34.6K ﹤0.01% 2839
2022
Q4 		$33.9M Buy
38,734
+2,705
+8% +$3.4M ﹤0.01% 2723
2022
Q3 		$39.6M Buy
36,029
+993
+3% +$1.31M ﹤0.01% 2626
2022
Q2 		$29M Buy
35,036
+4,043
+13% +$4.16M ﹤0.01% 2872
2022
Q1 		$48M Sell
30,993
-107
-0.3% -$144K ﹤0.01% 2619
2021
Q4 		$55.8M Buy
31,100
+833
+3% +$2.23M ﹤0.01% 2588
2021
Q3 		$99.9M Sell
30,267
-288
-0.9% -$1.01M ﹤0.01% 2213
2021
Q2 		$134M Buy
30,555
+24,852
+436% +$98.1M ﹤0.01% 2072
2021
Q1 		$27.6M Buy
5,703
+5,653
+11,306% +$31.9M ﹤0.01% 2999
2020
Q4 		$92K Buy
+50
New +$18.7K ﹤0.01% 4600
2020
Q2 		– Sell
-46
Closed -$12K – 5003
2020
Q1 		$12K Buy
46
+33
+254% +$18.6K ﹤0.01% 4682
2019
Q4 		$10K Buy
13
+3
+30% +$1.75K ﹤0.01% 4735
2019
Q3 		$4K Hold
10
– – ﹤0.01% 4795
2019
Q2 		$15K Buy
10
+9
+900% +$18.4K ﹤0.01% 4719
2019
Q1 		$3K Hold
1
– – ﹤0.01% 4777
2018
Q4 		$4K Buy
+1
New +$3.98K ﹤0.01% 4757

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock's BNGO Position: Q2 2026 in Review

BlackRock held its Bionano Genomics (BNGO) position steady in Q2 2026 at 9,937 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5426.

BlackRock first reported a position in BNGO in Q4 2018 and has held it in 29 quarters since. The position peaked at $134M in Q2 2021. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • BlackRock held 9,937 shares of Bionano Genomics worth $11.2K as of Q2 2026.
  • BlackRock left its Bionano Genomics share count unchanged in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5426 holding.
  • BlackRock first reported a position in Bionano Genomics in Q4 2018 and has held it in 29 quarters since.
  • BlackRock's Bionano Genomics position peaked at $134M in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.